Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

Prehospital delays to treatment can increase the mortality rate of NSTEMI patients up to 3 years later, according to new Korean data. While much emphasis has been placed on patient education aiming to ...

HealthDay News — Among young adults, first ST-segment elevation myocardial infarction (STEMI) in-hospital mortality increased from 2011 to 2022, according to a study published online February 26 in ...

PARIS, France—Among patients with acute MI and occlusive disease on invasive angiography, those presenting without ST-segment elevation on the initial ECG fare worse than those with STEMI, researchers ...

In a recent study published in The Lancet Regional Health - Europe, a group of researchers identified subpopulations at heightened risk for ST-elevation myocardial infarction (STEMI) and ...

The MedStar Southern Maryland Hospital Center in Clinton, Maryland, hosted a special Heart Month luncheon earlier this year, ...

The conventional wisdom of giving long-term beta-blockers for secondary prevention after myocardial infarction (MI), in the absence of another clinical indication, was questioned by a large cohort ...

WASHINGTON, DC – OCTOBER 29, 2024 – The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce ...